The U.S. Food and Drug Administration (FDA), is investigating a possible link between the use of Singulair and suicidal behavior, mood changes and suicide.Singulair, a leukotrient receptor antagonist, is used to treat asthma and the symptoms of rhinitis (irritation and inflammation of the nose), while preventing exercise-induced asthma episodes.Patients are advised not to stop taking Singluair...